2 research outputs found
<i>In Vitro</i> Multiwavelength PDT with <sup>3</sup>IL States: Teaching Old Molecules New Tricks
The purpose of the present investigation
was to ascertain whether <sup>3</sup>IL excited states with microsecond
lifetimes are universally
potent for photodynamic applications, and if these long-lived states
are superior to their <sup>3</sup>MLCT counterparts as <i>in
vitro</i> PDT agents. A family of blue-green absorbing, RuÂ(II)-based
transition metal complexes derived from the π-expansive dppn
ligand was prepared and characterized according to its photodynamic
activity against HL-60 cells, and toward DNA in cell-free media. Complexes
in this series that are characterized by low-energy and long-lived <sup>3</sup>IL excited states photocleaved DNA with blue, green, red,
and near-IR light. This panchromatic photodynamic effect translated
to <i>in vitro</i> multiwavelength photodynamic therapy
(PDT) with red-light cytotoxicities as low as 1.5 μM (EC<sub>50</sub>) for the parent complex and 400 nM for its more lipophilic
counterpart. This potency is similar to that achieved with RuÂ(II)-based
dyads containing long-lived <sup>3</sup>IL excitons located on appended
pyrenyl units, and appears to be a general property of sufficiently
long-lived excited states. Moreover, the red PDT observed for certain
members of this family was almost 5 times more potent than Photofrin
with therapeutic indices 30 times greater. Related RuÂ(II) complexes
having lowest-lying <sup>3</sup>MLCT states of much shorter duration
(≤1 μs) did not yield DNA photodamage or <i>in vitro</i> PDT with red or near-IR light, nor did the corresponding OsÂ(II)
complex with a submicrosecond <sup>3</sup>IL excited state lifetime.
Therefore, metal complexes that utilize highly photosensitizing <sup>3</sup>IL excited states, with suitably long lifetimes (≫
1 μs), are well-poised to elicit PDT at wavelengths even where
their molar extinction coefficients are very low (<100 M<sup>–1</sup> cm<sup>–1</sup>). Herein we demonstrate that such unexpected
reactivity gives rise to very effective PDT in the typical therapeutic
window (600–850 nm)
Ru(II) Dyads Derived from 2‑(1-Pyrenyl)‑1<i>H</i>‑imidazo[4,5‑<i>f</i>][1,10]phenanthroline: Versatile Photosensitizers for Photodynamic Applications
Combining
the best attributes of organic photosensitizers with
those of coordination complexes is an elegant way to achieve prolonged
excited state lifetimes in RuÂ(II) dyads. Not only do their reduced
radiative and nonradiative rates provide ample time for photosensitization
of reactive oxygen species at low oxygen tension but they also harness
the unique properties of <sup>3</sup>IL states that can act as discrete
units or in concert with <sup>3</sup>MLCT states. The imidazoÂ[4,5-<i>f</i>]Â[1,10]Âphenanthroline framework provides a convenient tether
for linking Ï€-expansive ligands such as pyrene to a RuÂ(II) scaffold,
and the stabilizing coligands can fine-tune the chemical and biological
properties of these bichromophoric systems. The resulting dyads described
in this study exhibited nanomolar light cytotoxicities against cancer
cells with photocytotoxicity indices exceeding 400 for some coligands
employed. This potency extended to bacteria, where concentrations
as low as 10 nM destroyed 75% of a bacterial population. Notably,
these dyads remained extremely active against biofilm with light photocytotoxicities
against these more resistant bacterial populations in the 10–100
nM regime. The results from this study demonstrate the versatility
of these highly potent photosensitizers in destroying both cancer
and bacterial cells and expand the scope of compounds that utilize
low-lying <sup>3</sup>IL states for photobiological applications